Clinical Trial Update: Antithrombotic Strategy Based on Clinical Events and 4D-CT for Patients After TAVR [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating an antithrombotic strategy guided by clinical events and 4D-CT imaging after transcatheter aortic valve replacement (TAVR).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Disease
• Bioprosthetic Valve Thrombosis
• Transcatheter Aortic Valve Replacement-associated Thrombosis

Snippet

Sponsor: China National Center for Cardiovascular Diseases | Conditions: Transcatheter Aortic Valve Replacement, Antithrombotic Therapy | Phase 4 | Status: UNKNOWN